COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.

Niccolò BuettiStéphane RucklyEtienne de MontmollinJean ReignierNicolas TerziYves CohenShidasp SiamiClaire DupuisJean François Timsit

Published in: Intensive care medicine (2021)

Using prospectively collected multicentric data, we showed that the ICU-BSI risk was higher for COVID-19 than non-COVID-19 critically ill patients after seven days of ICU stay. Clinicians should be particularly careful on late ICU-BSIs in COVID-19 patients. Tocilizumab or anakinra may increase the ICU-BSI risk.

Keyphrases

sars cov
intensive care unit
coronavirus disease
mechanical ventilation
palliative care
respiratory syndrome coronavirus
electronic health record
acute respiratory distress syndrome
big data
systemic lupus erythematosus
juvenile idiopathic arthritis